Year 2022 / Volume 114 / Number 1
Letter
Capecitabine-induced hyperammonemic encephalopathy

56

DOI: 10.17235/reed.2021.8129/2021

Carolina Cerrella Cano, Eduardo Junquera Alonso, Marina Terroba Alonso, Francisco Xavier Cano Calderero, Lucía Seoane Blanco, Edisa M. Armesto González,

Abstract
We report the case of a 79-year-old male who had undergone surgery for a mucus-secreting, stage-III pancreatic adenocarcinoma 2 years previously, who was recently started on capecitabine monotherapy for radiographic local progression. He developed disorientation, asterixis, nausea and elevated serum ammonia (221 μmol/L) 48-72 hours after treatment onset with preserved liver function. After ruling out potential causes of encephalopathy and tumor progression by abdominal and brain CT scans, his symptoms were related by exclusion to the recently initiated treatment with capecitabine. Capecitabine discontinuation, onset of standard anti-encephalopathy measures, and intravenous hydration led to a rapid, complete resolution of symptoms with serum ammonia normalization.
Share Button
New comment
Comments
No comments for this article
References
1. Sánchez Cánovas M, López Martín A. Severe gastrointestinal toxicity secondary to fluoropyrimidines: Acute esophageal necrosis associated extensive duodenal mucositis. Rev Esp Enferm Dig. 2020 Dec 2.
2. Mitani S, Kadowaki S, Komori A et al. Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy: A case series and review of the literature. Medicine (Baltimore). 2017 Jun;96(22):e6874.
3. Chahin M, Krishnan N, Chhatrala H et al. A 5-Fluorouracil-Induced Hyperammonemic Encephalopathy Challenged with Capecitabine, Case Reports in Oncological Medicine, vol.2020
4. Di Federico A, Nuvola G, Sisi M et al. Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible? Anticancer Drugs. 2020 Nov;31(10):1103-1105.
Citation tools
Cerrella Cano C, Junquera Alonso E, Terroba Alonso M, Cano Calderero F, Seoane Blanco L, Armesto González E, et all. Capecitabine-induced hyperammonemic encephalopathy. 8129/2021


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 589 visits.
This article has been downloaded 160 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 01/06/2021

Accepted: 03/06/2021

Online First: 22/06/2021

Published: 10/01/2022

Article Online First time: 21 days

Article editing time: 223 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology